GENZYME - THE KING OF THE BIOTECHS Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GENZYME - THE KING OF THE BIOTECHS

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: H. Bradley Toland, Jr. who wrote (262)	3/16/1998 12:34:00 PM
From: Harold Engstrom	Read Replies (1) of 410

Bradley, I bought this stock in summer '96 and it has moved up from 22 to now 32. But, it was trading as high as 35 during the year priior to my purchase and it really has been something of an underachiever, in my opinion. The market thinks so as well, since it has moved laterally for the past three years. The company has a special charge every quarter - so they might as well stop calling these charges "special"! Still, I think this company will succeed in the long haul - although it is easy to see why investors like aliveinsf are frustrated.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next